SUROVATAMIG

UNII:	3QW12I37H1
Formula:
Preferred Substance Name:	SUROVATAMIG
GSRS Full Record:	3QW12I37H1 i

2892667-02-4
AZD0486
AZD-0486
IMMUNOGLOBULIN (H-GAMMA4_L-KAPPA)_VH-G4(H-CH2-CH3), ANTI-(HOMO SAPIENS CD3D (CD3 DELTA) AND CD3E (CD3 EPSILON, LEU-4) DIMER) AND ANTI-(HOMO SAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)), HOMO SAPIENS AND HUMANIZED MONOCLONAL ANTIBODY ASYMETRIC, BISPECIFIC, BIVALENT
IMMUNOGLOBULIN G4 (231-PROLINE,237-ALANINE,238-ALANINE,369-TRYPTOPHAN), BISPECIFIC, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AZD0486 .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL AZD0486 .KAPPA.-CHAIN, (229->124'),(232->127')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN (126-PROLINE,132-ALANINE,133-ALANINE) ANTI-(CD19 ANTIGEN) (HUMAN SINGLE-DOMAIN VARIABLE REGION) FUSION PROTEIN WITH 219-447-IMMUNOGLOBULIN G4 (228-PROLINE,234-ALANINE,235-ALANINE,366-SERINE,368-ALANINE,407-VALINE) (HUMAN MONOCLONAL AZD0486 .GAMMA.4-CHAIN)
SUROVATAMIG [INN]
SUROVATAMIG [WHO-DD]
TNB-486

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SUROVATAMIG

Synonyms and Mappings

Resources